Seraxis
Ian McWilliams has a diverse work experience that includes roles in project management, cell culture science, and research. Ian is currently employed at Seraxis as a Project Manager since March 2022 and previously worked as a Cell Culture Scientist from March 2021 to March 2022. Before joining Seraxis, Ian held the position of Senior Research Associate at Sanaria Inc. from April 2018 to March 2021. Prior to that, they worked as a Research Assistant at Tulane University School of Public Health and Tropical Medicine from February 2016 to June 2017.
Ian McWilliams completed their education with a Bachelor of Science degree in Biology, specializing in General Biology, from Berry College. Ian attended Berry College from 2011 to 2015. Following that, they pursued a Master of Science degree in Public Health and Tropical Medicine at the Tulane University School of Public Health and Tropical Medicine. Ian completed their Master's program from 2015 to 2017. In addition to their formal education, they obtained a certification in Pharmaceutical Contamination Control from the Biopharma Institute in December 2021.
This person is not in any teams
Seraxis
Seraxis is a private biotechnology company launched in March 2013. Incorporated in Singapore and the United States, their GMP lab is located in Germantown, Maryland. Seraxis team of scientists developed novel cell and encapsulation technologies. Their main goal is to bring a practical cell therapy for insulin-dependent diabetes to the clinic andprovide a long term cure to patients that does not require the use of immuno-suppression.Their corporate structure and strategy is designed to achieve that goal as quickly as possible, while bringing maximum value to their shareholders.